The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

Manmeet Ahluwalia, MD, MBA, FASCO, discusses the prevalence of brain metastases in patients with primary renal cell carcinoma.

The FDA granted priority review to sunvozertinib for the treatment of advanced NSCLC with EGFR exon 20 mutations, based on ...

Investing.com -- Shares of Vir Biotechnology, Inc. (NASDAQ: VIR) surged 29% following the release of encouraging safety and efficacy data from ongoing dose escalation trials for its dual-masked T-cell ...

Johnson & Johnson said it received positive topline results in a Phase 3 study of a combination of drugs to treat patients with locally advanced or metastatic non-small cell lung cancer.

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.